Cargando…
肺腺癌EGFR与KRAS基因突变状态分析
BACKGROUND AND OBJECTIVE: Mutations in epidermal growth factor receptor (EGFR) and KRAS are important markers in non-small cell lung cancer, which are closely related to the clinical therapeutic effect. To analysis the EGFR and KRAS gene mutation rate and its relationship with clinical features in p...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000313/ https://www.ncbi.nlm.nih.gov/pubmed/26582224 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.11.05 |
Ejemplares similares
-
肺鳞癌EGFR与KRAS基因突变状态分析
Publicado: (2015) -
吉非替尼治疗EGFR基因突变状态不明的青年晚期肺腺癌疗效分析
Publicado: (2014) -
维吾尔族肺腺癌患者的EGFR基因突变分析
Publicado: (2013) -
浸润性肺腺癌EGFR、ALK基因突变状态与影像学、病理学特征的相关性
Publicado: (2022) -
晚期肺腺癌患者化疗前后血清EGFR基因突变状态的比较
Publicado: (2011)